Cambrex
About
Company description
Cambrex is the leading small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world.
- We put all of our energy and experience into being your partner of choice
- We create value for customers through manufacturing excellence, reliable quality and innovative science
- Our people are the experts that our customers enjoy working with We truly offer our customers an end-to-end partnership for the research, development and manufacture of small molecule therapeutics at every stage of the drug lifecycle.
Quick facts
| Affiliated categories: | API Contract Manufacturing |Bio Services |Contract Manufacturing More |
|---|
Upcoming events
CPhI Worldwide 2019
5-7 November 2019 Frankfurt, Germany Visit us at stand 41C10 Book a meeting See our Exhibitor Profile See full Exhibitor ListCPhI & PMEC China 2019
18 - 21 June, 2019 Shanghai, China Visit us at stand E1A58 Book a meeting See our Exhibitor Profile See full Exhibitor ListCPhI North America 2019
30 April - 2 May 2019 Chicago, USA Visit us at stand 1006 Book a meeting See our Exhibitor Profile See full Exhibitor ListRecently at
CPhI Worldwide 2018
9 - 11 October 2018 Madrid, Spain We were at stand 5G12 See our Exhibitor Profile See full Exhibitor ListCPhI North America 2018
24-26 April, 2018 Philadelphia, USA We were at stand 613 See our Exhibitor Profile See full Exhibitor ListCPhI Worldwide 2017
24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 80G40 See our Exhibitor Profile See full Exhibitor ListNews about Cambrex
2 Jan 2019
Cambrex completes acquisition of Avista Pharma Solutions
Acquisition adds a full complement of early-stage development capabilities to Cambrex’s larger scale capabilities for APIs and finished dosage forms.
Read more12 Dec 2018
Cambrex expands analytical capabilities
The $1 million investment will assist in getting new products to commercial launch faster.
Read more20 Nov 2018
Acquisition boosts Cambrex's early-stage development capabilities
Acquisition adds early-stage API and finished dosage form development & testing services to its global contract development & manufacturing network.
Read more16 Oct 2018
Cambrex invests $3m to upgrade generic API manufacturing facilities at Milan site
The investment increases the overall capacity and capabilities of the facility, and its flexibility.
Read moreContent
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation